Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

UROMODULIN AND RISK OF UPPER URINARY TRACT INFECTIONS: A MENDELIAN RANDOMIZATION STUDY

View ORCID ProfileKristin Vardheim Liyanarachi, View ORCID ProfileHelene Flatby, View ORCID ProfileStein Hallan, View ORCID ProfileBjørn Olav Åsvold, View ORCID ProfileJan Kristian Damås, View ORCID ProfileTormod Rogne
doi: https://doi.org/10.1101/2024.06.18.24309082
Kristin Vardheim Liyanarachi
1Mid-Norway Center for Sepsis Research, Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Infectious Diseases, Clinic of Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristin Vardheim Liyanarachi
  • For correspondence: kristin.v.liyanarachi{at}ntnu.no
Helene Flatby
1Mid-Norway Center for Sepsis Research, Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
3Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helene Flatby
Stein Hallan
3Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
4Department of Nephrology, Clinic of Medicine, St Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stein Hallan
Bjørn Olav Åsvold
5HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
6Department of Endocrinology, Clinic of Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
7HUNT Research Center, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bjørn Olav Åsvold
Jan Kristian Damås
1Mid-Norway Center for Sepsis Research, Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Infectious Diseases, Clinic of Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim, Norway
3Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Kristian Damås
Tormod Rogne
8Yale Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA
1Mid-Norway Center for Sepsis Research, Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tormod Rogne
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Observational studies have suggested that uromodulin, produced by the kidneys, may reduce the risk of upper urinary tract infections, but are limited by potential confounding. To address this concern, we conducted a two-sample Mendelian randomization study to explore this association.

Methods We identified uncorrelated (r2< 0.01) single nucleotide polymorphisms strongly associated (p<5 × 10−6) with urinary and serum uromodulin from two genome-wide association studies. Both studies accounted for kidney function. Genetic associations for the risk of upper urinary tract infections were extracted from an independent genome-wide association study. Inverse-variance weighted and sensitivity analyses were performed.

Results The study included 29,315 and 13,956 participants with measured urinary and serum uromodulin, respectively, and 3,873 and 512,608 subjects with and without upper urinary tract infections. A one standard deviation increase in genetically predicted urinary uromodulin was associated with an odds ratio for upper urinary tract infections of 0.80 (95% confidence interval 0.67 to 0.95, p = 0.01). For serum uromodulin, a one standard deviation increase was associated with an odds ratio of 0.95 (95% confidence interval 0.89 to 1.01, p = 0.12). The results were consistent across sensitivity analyses.

Conclusion In this two-sample mendelian randomization study we found that increased levels of genetically predicted urinary uromodulin were associated with a reduced risk of upper urinary tract infections. A similar trend was observed for serum uromodulin. Our findings align with results from traditional observational studies which together support that uromodulin may have a protective role against upper urinary tract infections

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by Samarbeidsorganet Helse Midt-Norge, NTNU (Norwegian University of Science and Technology) (Trondheim, Norway) (KL). Open access funding provided by NTNU Norwegian University of Science and Technology (incl St. Olavs Hospital - Trondheim University Hospital). TR was funded by CTSA Grant Number UL1 TR001863 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of NIH. None of the authors or their institutions have at any time received payment or services from a third party for any aspect of the submitted work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We only used summary-level data from studies with relevant participant consent and ethical approval, and ethical approval from an institutional review board was therefore not necessary for the present study. Links to published GWASs: doi: 10.1681/ASN.2021040491.doi: 10.1172/jci.insight.157035 doi: 10.1093/infdis/jiae231

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 19, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
UROMODULIN AND RISK OF UPPER URINARY TRACT INFECTIONS: A MENDELIAN RANDOMIZATION STUDY
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
UROMODULIN AND RISK OF UPPER URINARY TRACT INFECTIONS: A MENDELIAN RANDOMIZATION STUDY
Kristin Vardheim Liyanarachi, Helene Flatby, Stein Hallan, Bjørn Olav Åsvold, Jan Kristian Damås, Tormod Rogne
medRxiv 2024.06.18.24309082; doi: https://doi.org/10.1101/2024.06.18.24309082
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
UROMODULIN AND RISK OF UPPER URINARY TRACT INFECTIONS: A MENDELIAN RANDOMIZATION STUDY
Kristin Vardheim Liyanarachi, Helene Flatby, Stein Hallan, Bjørn Olav Åsvold, Jan Kristian Damås, Tormod Rogne
medRxiv 2024.06.18.24309082; doi: https://doi.org/10.1101/2024.06.18.24309082

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)